Friday, May 15, 2015

Last Chance to Save Up To $550 off Immuno-Oncology

As research in cancer immunotherapies continues to rapidly evolve, it is critical to separate the real opportunities from the hype. There has been great progress with checkpoint inhibitors, CAR-T and T-Cell therapies, cancer vaccines, agnostic antibodies, and combination therapies.

IBC's Immuno-Oncology provides the critical insights and strategies you need to improve response rates, efficacy, and get closer to a cure!

Download the full agenda for complete session and speaker information here:

Advancing the Next Generation of Cancer Immunotherapies
September 30 – October 1, 2015
Hilton Alexandria Mark Center, Alexandria, VA

Visit the website for more details:

Don't miss out on maximum savings for IBC's Immuno-Oncology!

Register by May 15 to Save up to $550 off the standard rates:

Register today and explore the latest advances in Immuno-Oncology to:
-          Design next generation immunotherapies by understanding recent advances made with CAR-T and T-Cell therapies, checkpoint inhibitors, cancer vaccines, and agnostic antibodies
-          Develop a successful combination therapy strategy by gaining insights from global leaders on effective combinations
-          Improve the discovery and development of your promising immunotherapies by hearing best practices and lessons learned from the first wave of cancer immunotherapies

The Immuno-Oncology Team 2015

Share this article with your social network, just click below to share now!

No comments :

Post a Comment